Raia Drogasil (OTCMKTS:RADLY – Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.05 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.05, Zacks reports. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%.
Raia Drogasil Stock Performance
Shares of OTCMKTS RADLY traded down $0.15 during trading hours on Tuesday, reaching $2.70. The stock had a trading volume of 25,105 shares, compared to its average volume of 83,417. The firm has a market cap of $3.55 billion and a price-to-earnings ratio of 17.98. The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99. Raia Drogasil has a fifty-two week low of $2.63 and a fifty-two week high of $5.34. The firm has a 50-day moving average of $3.72 and a 200-day moving average of $4.07.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group upgraded shares of Raia Drogasil to a “buy” rating and set a $5.20 target price for the company in a report on Sunday, October 18th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Raia Drogasil presently has an average rating of “Moderate Buy” and an average price target of $5.20.
Read Our Latest Report on RADLY
About Raia Drogasil
Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.
The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.
RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.
Featured Stories
- Five stocks we like better than Raia Drogasil
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
